|
Q1 FY2025
As of May 4, 2024
|
Q4 FY2024
As of Feb 3, 2024
|
Q3 FY2024
As of Oct 28, 2023
|
Q2 FY2024
As of Jul 29, 2023
|
Q1 FY2024
As of Apr 29, 2023
|
Q4 FY2023
As of Jan 28, 2023
|
Q3 FY2023
As of Oct 29, 2022
|
Q2 FY2023
As of Jul 30, 2022
|
Q1 FY2023
As of Apr 30, 2022
|
Q4 FY2022
As of Jan 29, 2022
|
Q3 FY2022
As of Oct 30, 2021
|
Q2 FY2022
As of Jul 31, 2021
|
Q1 FY2022
As of May 1, 2021
|
Q4 FY2021
As of Jan 30, 2021
|
Q3 FY2021
As of Oct 31, 2020
|
Q2 FY2021
As of Aug 1, 2020
|
Q1 FY2021
As of May 2, 2020
|
Q4 FY2020
As of Feb 1, 2020
|
Q3 FY2020
As of Nov 2, 2019
|
Q2 FY2020
As of Aug 3, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating right-of-use assets | ||||||||||||||||||||
| Finance right-of-use assets, net | ||||||||||||||||||||
| Tradename intangible asset | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Other assets, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' INVESTMENT | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Operating lease obligations | ||||||||||||||||||||
| Credit facility | ||||||||||||||||||||
| Finance lease obligations | ||||||||||||||||||||
| Accrued payroll expenses | ||||||||||||||||||||
| Other accrued expenses | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Operating lease obligations | ||||||||||||||||||||
| Finance/capital lease obligations | ||||||||||||||||||||
| Finance lease obligations | ||||||||||||||||||||
| Unrecognized tax benefits | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' investment: | ||||||||||||||||||||
| Preferred stock, $0.01 par value, no shares issued | ||||||||||||||||||||
| Common stock - 40,384; 40,170; and 40,120 shares issued, respectively | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost; 26,855,158, 26,317,947 and 23,483,504 shares repurchased, respectively | ||||||||||||||||||||
| Treasury stock, at cost - 28,436; 28,376; and 27,373 shares repurchased, respectively | ||||||||||||||||||||
| Total stockholders' investment | ||||||||||||||||||||
| Total liabilities and stockholders' investment | ||||||||||||||||||||
| Common stock, authorized (in shares) | ||||||||||||||||||||
Loading...
